Top Story

New year, new code: How to get paid for chronic care management in 2015, part 1

December 18, 2014

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

Beginning in 2015, physicians and other qualified health care professionals will be able to separately bill Medicare for providing non-face-to-face chronic care management services by billing CPT code 99490.

Chronic care management (CCM) includes the development and/or revision of a patient-centered plan of care, coordination with other treating health care professionals and medication management. As detailed below, CCM payments will potentially be available to eligible providers for furnishing at least 20 minutes of non-face-to-face services to qualified beneficiaries during a calendar month.

FDA News

FDA announces members of its Pharmacy Compounding Committee

December 18, 2014
The FDA has announced the roster of its new Pharmacy Compounding Advisory Committee, the agency announced in a press release. The 14-member committee includes a lineup…

Top honors awarded to web resources from the Endocrine Society

December 17, 2014
Top honors in the Summer/Fall 2014 Web Health Awards Competition have been awarded to two of the Endocrine Society’s consumer health education websites, according…
In the Journals

More studies urged in managing posttreatment fatigue in thyroid cancer

December 17, 2014
A paucity of reliable trials exists to guide evidence-based management of posttreatment fatigue in thyroid cancer survivors, according to a systematic review published…
In the Journals

Polyphenol supplement failed to improve NAFLD in obese men

December 17, 2014
Resveratrol did not improve characteristics of nonalcoholic fatty liver disease among a cohort of overweight or obese men, according to study data.“We hypothesized…
More News Headlines »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
thumbnail for video 3890508474001

Lenvatinib, sorafenib may significantly impact treatment of differentiated thyroid cancer

November 13, 2014
Marcia S. Brose, MD, PhD, associate professor at the University of Pennsylvania and director of the thyroid cancer…
More »
CME
Screening and Treatment of Diabetes-Associated Eye Disease

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »
morganatic-roan
morganatic-roan